A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Name: A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
License: Public Domain

The First Affiliated Hospital with Nanjing Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

gastric cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 252979
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.